Alprostadil (Caverject/MUSE) Cost in Mississippi 2026

What Does Alprostadil Actually Cost in Mississippi Right Now?

The average cash-pay price for brand-name alprostadil at Mississippi retail pharmacies in 2026 is approximately $600 per month, which aligns with the national manufacturer list price set by Pfizer and generic producers. Good RX and pharmacy benefit data confirm this range holds across Jackson, Gulfport, Hattiesburg, and Tupelo zip codes. That figure covers a typical on-demand supply of six Caverject 20-mcg cartridges or a comparable quantity of MUSE suppositories.

Alprostadil is prostaglandin E1 (PGE1). It relaxes smooth muscle in the corpus cavernosum, increasing arterial inflow and producing an erection within 5 to 20 minutes of administration. The FDA approved intracavernosal alprostadil (Caverject) in 1995 and the intraurethral pellet (MUSE) in 1996. Both forms require a prescription in Mississippi, as in every other state.

The landmark Linet et al. trial published in the New England Journal of Medicine reported that intracavernosal alprostadil produced satisfactory erections in 94% of men with vasculogenic or psychogenic erectile dysfunction across 12 weeks of use (N=296). Efficacy that high makes it a standard second-line therapy when oral phosphodiesterase-5 inhibitors fail or are contraindicated.

Price variation within Mississippi is modest. Independent pharmacies in rural counties may charge $20, $40 more per fill than big-box chains because of lower purchasing volume. Compounding pharmacies, covered in a separate section below, represent the largest potential price break.

How Mississippi Medicaid Handles Alprostadil Coverage

Mississippi Medicaid does not cover alprostadil or any other erectile dysfunction medication under its standard fee-for-service or managed care benefits. This exclusion applies to Caverject, MUSE, and generic alprostadil injection kits alike.

The Centers for Medicare and Medicaid Services allows states to exclude drugs used for erectile dysfunction from Medicaid formularies under 42 U.S.C. § 1396r-8(d)(2). Mississippi exercises that exclusion in full. There is no prior authorization pathway that unlocks coverage, even for men with documented post-prostatectomy or diabetic neuropathy-related ED.

Diabetes affects an estimated 15.4% of Mississippi adults, the highest state prevalence in the nation according to CDC surveillance data. Men with diabetes-related ED are therefore disproportionately affected by this coverage gap. Alprostadil is often the appropriate next step when metformin and glycemic control alone do not restore erectile function and oral PDE5 inhibitors are ineffective or cause unacceptable hypotension.

Medicare Part D similarly excludes erectile dysfunction drugs by statute. Dual-eligible Mississippi residents enrolled in both Medicaid and Medicare Part D face the same coverage wall from both programs simultaneously.

If alprostadil is prescribed for a non-ED indication such as pulmonary arterial hypertension or peripheral arterial occlusive disease, coverage rules differ and must be confirmed with the individual plan.

Is Compounded Alprostadil Legal in Mississippi?

Compounded alprostadil is legal in Mississippi when prepared by a state-licensed pharmacy operating under USP <797> standards as a 503A compounding facility. Mississippi's State Board of Pharmacy licenses and inspects 503A pharmacies under Miss. Code Ann. § 73-21-73, and federal oversight by the FDA applies to any sterile preparations.

The FDA's guidance on compounding distinguishes 503A pharmacies, which serve individual patient prescriptions, from 503B outsourcing facilities, which can produce larger batch quantities. Most Mississippi-licensed compounding pharmacies operate under 503A, meaning a valid patient-specific prescription from a licensed Mississippi prescriber is required before any compounded alprostadil can be dispensed.

Compounded alprostadil formulations commonly dispensed at 503A pharmacies include:

• Alprostadil alone for intracavernosal injection (typically 10 to 40 mcg/mL vials)
• Trimix (alprostadil, phentolamine, papaverine) for intracavernosal injection
• Bimix (alprostadil plus papaverine)

Trimix formulations have shown equivalent or superior efficacy to alprostadil monotherapy in head-to-head comparisons, with one series reporting 92% patient satisfaction vs. 87% for alprostadil alone. The compounded cost for a multi-dose Trimix vial typically falls in the $60, $150 range at Mississippi-licensed pharmacies, compared to the $600 monthly cash price for brand Caverject.

The HealthRX clinical team has developed the following decision framework for Mississippi patients choosing between brand, generic, and compounded alprostadil:

Step 1. Confirm commercial insurance formulary status first (see next section). Step 2. If covered with a high copay, apply the Pfizer savings card or manufacturer patient assistance program. Step 3. If uninsured or on Medicaid, request a 503A compounding pharmacy quote for Trimix or alprostadil monotherapy before paying brand cash price. Step 4. If the prescriber is comfortable with self-injection training via telehealth, an out-of-state 503A pharmacy licensed in Mississippi may offer further savings.

Which Private Insurance Plans Cover Alprostadil in Mississippi?

Coverage depends entirely on the specific plan, not on the insurer's name. Blue Cross Blue Shield of Mississippi, UnitedHealthcare, Aetna, Humana, and Cigna all sell individual and group plans in Mississippi. Some tiers within those plans include alprostadil on formulary; most do not.

The American Urological Association guideline on erectile dysfunction recommends intracavernosal alprostadil as a second-line therapy after PDE5 inhibitor failure, which can strengthen a prior authorization request. Documenting PDE5 inhibitor failure, contraindication, or intolerance in the medical record is the single most effective step a prescriber can take when appealing a denial.

A 2023 analysis in JAMA Network Open found that coverage of erectile dysfunction treatments varied by more than 40 percentage points across ACA marketplace plans, with alprostadil covered less frequently than oral PDE5 inhibitors. Patients with employer-sponsored plans subject to ERISA may have stronger appeal rights than those on ACA marketplace plans, because ERISA plans cannot categorically exclude a drug that is medically necessary for a covered condition such as post-surgical ED.

Steps to verify coverage in Mississippi:

1. Call the member services number on your insurance card and ask specifically for the formulary tier for NDC 00009-3442-01 (Caverject 10 mcg) or NDC 00009-3441-01 (Caverject 20 mcg).
2. Ask whether a quantity limit applies and what the prior authorization criteria are.
3. Request the formulary exception form if alprostadil is not listed, and have your urologist or telehealth provider document medical necessity.

How the Pfizer Savings Card and Patient Assistance Programs Work in Mississippi

Pfizer's copay assistance card for Caverject reduces out-of-pocket cost to as low as $0 per fill for eligible commercially insured patients. The program is administered through Pfizer's patient assistance portal and is subject to income and insurance eligibility requirements. Patients enrolled in any federal or state government health program, including Mississippi Medicaid or Medicare Part D, are explicitly excluded from the copay card under federal anti-kickback safe harbor rules.

Pfizer's RxPathways program provides free or reduced-cost Caverject to uninsured or underinsured patients who meet income criteria, typically set at or below 400% of the federal poverty level. An application requires a prescriber signature and proof of income.

NeedyMeds and the Partnership for Prescription Assistance also list alprostadil programs that Mississippi residents can apply for through their physician or telehealth provider. The NeedyMeds database currently lists three separate patient assistance pathways for branded alprostadil products.

For generic alprostadil injection kits, no branded manufacturer savings program exists. GoodRx and RxSaver coupons routinely reduce the retail price to $180, $320 for a six-cartridge supply at major Mississippi chains, a 47 to 70% reduction off the $600 list price.

Telehealth Prescribing of Alprostadil in Mississippi

A Mississippi-licensed physician or advanced practice provider can prescribe alprostadil via a synchronous telehealth visit in 2026. Mississippi expanded telehealth prescribing authority through Miss. Code Ann. § 83-9-351, and the state's Board of Medical Licensure has not carved out erectile dysfunction medications from telehealth-eligible prescriptions.

Telehealth-based care for erectile dysfunction has demonstrated patient satisfaction rates above 80% in prospective studies, with no significant difference in adverse event rates compared to in-person initiation. Self-injection technique, however, does require a structured training component. Most telehealth platforms accomplish this through a recorded video demonstration followed by a real-time video check-in during the patient's first self-administration.

The prescriber must hold an active Mississippi medical license or a Mississippi telehealth registration if based in another state. Prescriptions sent to an out-of-state 503A pharmacy must comply with both Mississippi pharmacy law and the dispensing state's law.

Telehealth visits for alprostadil initiation at HealthRX typically involve:

• Review of prior PDE5 inhibitor trial documentation
• Cardiovascular risk stratification using the Princeton Consensus III criteria
• Baseline assessment for Peyronie's disease, which affects up to 9% of men and may alter injection site selection
• Prescription of the lowest effective starting dose (5 mcg for Caverject) with titration instructions
• Follow-up at two weeks to confirm technique and adjust dose

Clinical Pharmacology: What Mississippi Patients Should Know Before Starting

Alprostadil binds EP2 and EP3 prostanoid receptors on smooth muscle cells in the corpus cavernosum, activating adenylyl cyclase and raising intracellular cyclic AMP. This mechanism is entirely distinct from PDE5 inhibition, which is why alprostadil remains effective in men who do not respond to sildenafil or tadalafil.

The Linet et al. NEJM trial (N=296) reported that intracavernosal alprostadil produced erections rated satisfactory for intercourse in 87% of at-home attempts, compared to 37% for placebo injections (P<0.001). Penile pain occurred in 50% of participants but led to discontinuation in only 11%.

Contraindications to alprostadil include:

• Hypersensitivity to prostaglandin E1
• Conditions predisposing to priapism: sickle cell anemia, multiple myeloma, leukemia
• Anatomical penile deformity that would prevent proper injection
• Penile implant already in situ

The American Urological Association notes that the risk of priapism with intracavernosal alprostadil is approximately 1% per injection, with the majority of cases resolving with intracavernosal phenylephrine injection at 200 to 500 mcg. Patients starting therapy in Mississippi should be advised to go to an emergency department if erection persists beyond four hours.

Dose titration for Caverject follows a supervised in-office or telehealth protocol: start at 2.5 mcg in men with neurogenic ED or 5 mcg in vasculogenic ED, increase by 2.5 to 5 mcg increments until an erection adequate for intercourse occurs without persisting beyond one hour. The maximum recommended dose is 60 mcg, though most men respond between 10 to 20 mcg.

MUSE suppositories begin at 125 mcg. Clinical data show a response rate of approximately 43% for MUSE vs. 65 to 87% for intracavernosal injection, making injection the preferred route when the patient is comfortable with self-administration. MUSE does not require injection technique training, which matters for patients with needle phobia.

Side Effects and Drug Interactions Relevant to Mississippi Patients

The most frequently reported side effects across both formulations are penile pain (50% intracavernosal, 36% intraurethral), urethral burning (MUSE-specific, approximately 32%), hypotension (3%), and prolonged erection (1 to 4%). The FDA prescribing information for Caverject Impulse lists hypotension as the most clinically significant systemic adverse effect, particularly relevant in men taking antihypertensive medications.

Mississippi has a high burden of cardiovascular disease. The CDC reports age-adjusted heart disease death rates in Mississippi at 237.9 per 100,000, the second highest in the nation. Men on nitrates, alpha-blockers, or multiple antihypertensives face a meaningful risk of orthostatic hypotension after alprostadil use. The Princeton Consensus III guidelines recommend cardiac risk stratification before initiating any ED pharmacotherapy; intermediate-risk patients should undergo stress testing before alprostadil is prescribed.

Concurrent use of anticoagulants such as warfarin increases the risk of injection-site hematoma; patients on warfarin should aim for an INR <3.0 before self-injecting and apply firm pressure for at least five minutes post-injection.

How to Get Alprostadil in Mississippi: A Step-by-Step Cost Minimization Path

Most Mississippi men paying out of pocket can reduce their annual alprostadil spend from $7,200 (brand cash) to under $2,000 by following a structured sequence.

Step 1: Check commercial insurance first. Even a Tier 4 specialty copay of $150/month is 75% less than cash price. Submit a prior authorization with AUA guideline language and document PDE5 inhibitor failure.

Step 2: Apply the Pfizer copay card immediately. If commercially insured and the card applies, cost drops to $0, $35/fill. Enrollment takes under five minutes at Pfizer's patient assistance website.

Step 3: Request a compounded Trimix quote. A Mississippi-licensed 503A pharmacy can legally dispense compounded Trimix for $60, $150 per multi-dose vial under a valid prescription. Compounded Trimix has demonstrated efficacy comparable to alprostadil monotherapy in prospective comparisons, with some studies showing higher satisfaction scores due to lower rates of penile pain.

Step 4: Use GoodRx if none of the above applies. GoodRx coupons reduce generic alprostadil injection kits to $180, $320 at Mississippi chains including CVS, Walgreens, and Walmart. No enrollment is required; print or display the coupon at the pharmacy counter.

Step 5: Apply to RxPathways or NeedyMeds if uninsured and income-eligible. The application takes two to four weeks. Pfizer's patient assistance program has provided Caverject at no cost to more than 1 million low-income patients since its launch according to Pfizer's published program statistics.

Alprostadil vs. Other ED Treatments: Cost Comparison for Mississippi Men

Oral PDE5 inhibitors remain first-line for most men because generic sildenafil now costs as little as $0.50, $2.00 per tablet at Mississippi pharmacies. The AUA erectile dysfunction guideline (2018, amended 2022) positions oral PDE5 inhibitors as first-line, intracavernosal alprostadil as second-line, and penile prosthesis implantation as third-line therapy.

For men who have failed two or more PDE5 inhibitors at maximum tolerated doses, or who have contraindications such as concurrent nitrate use, alprostadil becomes the appropriate next step. A systematic review in the Cochrane Database found that intracavernosal alprostadil produced successful intercourse in 60 to 87% of men with organic ED who had failed oral therapy, compared to 12 to 37% for intraurethral delivery routes.

Vacuum erection devices carry a one-time cost of $150, $400 and have no ongoing supply expense. They are covered by Medicare Part B as durable medical equipment when prescribed for certain post-surgical indications. For cost-sensitive Mississippi men, a vacuum device combined with an on-demand low-dose compounded Trimix injection represents the lowest annual out-of-pocket option outside of full insurance coverage.

Penile prosthesis implantation averages $20,000, $30,000 including hospital fees and surgeon costs in Mississippi. Some commercial plans and Medicare cover the procedure when conservative therapies have failed, but prior authorization criteria are strict.